Message from the Chair

The Scientific Liaison Coalition (SLC) was established to foster stronger scientific collaboration to promote human health. Our core guiding principle is that increased collaboration among scientists across sectors (academia, industry, government) and spanning diverse disciplines drives scientific progress that directly improves public and environmental health.

Our member organizations benefit from global partnerships, the advancement of interdisciplinary scientific collaboration, and access to exclusive member-only content. We operate through virtual monthly teleconferences and an annual face-to-face gathering. These opportunities help raise awareness of member society events, scientific meetings and publications, and provide updates on the progress of SLC-planned initiatives.

Currently, the SLC comprises 13 member organizations. Since its creation in 2008, SLC has established a variety of work groups to explore and address cross-cutting issues of shared interest and impact on our members. The SLC currently has five active work groups: Animal Models and Alternatives; Dose-Dependent Mechanisms of Action; Neuro Topics; Occupational Exposures; and Psychedelics and Cannabis. Although these groups have specific objectives, many intergroup activities are developed. During the past year, SLC work groups organized events and activities on multiple topics. The member society SLC representatives are encouraged to share the activities of the SLC work groups with the leadership and members of their societies.

The enthusiasm and hard work ethic in the Animal Models and Alternatives WG was rooted in a WG-authored publication entitled Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods (doi:10.1124/pharmrev.123.000967) that was published in 2024 in Pharmacological Reviews. Since then, these data have been shared in PLOS SciComm blog, and as posters at many of the SLC Society members’ meetings, including BDRP and IUTOX’s CTDC. Moreover, the WG has continued the goal of keeping animal models, alternatives, and NAMs in the forefront of toxicology through participation in various workshops, one of which led to another WG-authored publication entitled Identifying the Gaps and Opportunities for NAMs Application in Regulatory Toxicology (doi:10.1016/j.cotox.2026.100591) that was published in Current Opinion in Toxicology in 2026. Given the WG's interest in open discussions about animal models, alternatives, and NAMs, the WG is currently working on an educational survey to define the degree to which these subjects are taught in professional schools in the US. Work is underway to contact survey responders, with the idea that the data will be reported in an eventual publication.

The Dose-Dependent Mechanisms of Action Work Group (our newest WG) has outlined a manuscript and selected initial co-authors from BDRP, SOT, ATS, and other societies to address the issue of dose-dependent determinants of biologic plausibility. Additional members are encouraged to join the WG. The ten current members of the manuscript drafting team are committed to supplying an example of dose-dependent mechanisms to be discussed as possible topics for manuscript development. Several examples have been submitted to the group and discussed at the monthly zoom meetings. The goal of the team is to have a draft of the manuscript focused on dose-dependency ready for submission by March 2027.

The Neuro WG is also new this year and has already attracted many members from SLC Societies as it has focused on and outlined a possible webinar or manuscript on the topic of AI application to neurotoxicity and brain imaging.

The Occupational Exposures work group offered the CE Course on Considerations for Occupational Risk Management during Pregnancy at the Congress of Toxicology in Developing Countries held at the American Industrial Health Association meeting, May 2025. The presentations of this course have been compiled in a manuscript (doi:10.1177/07482337241273833).

The Psychedelics and Cannabis Work Group has developed and published a COTOX Special Issue including 14 chapters and an introduction entitled Psychedelics and Cannabis: Toxicological Perspectives and Public Health Challenges. The Work Group is also partnering with Arizona State University to develop a virtual conference proposal entitled Emerging Therapeutics and Safety – Bridging the Science and Policy of Cannabis and Psychedelics. This includes a preconference kick-off networking happy hour event during the 2027 San Antonio SOT Annual Meeting.

Work group activities are fundamental for SLC development. Some challenging issues are in discussion, such as the implementation of NAMs in the regulatory sector, the future of animal models, psychedelic and cannabis use, developmental and reproductive toxicology, environmental contaminants in psychedelics and cannabis, and challenges in communicating the exposure-related risk of psychedelics and cannabis, among others.

SLC’s activities only happen thanks to the voluntary commitment, expertise, and enthusiasm of its members’ representatives

I extend my sincere gratitude to the current SLC Work Group Chairs, Co-Chairs, and active members for their dedication and hard work in maintaining a strong, impactful SLC. We are committed to serving our member societies by increasing collaboration among scientists to directly improve public and environmental health.

Best regards,

William Slikker Jr., PhD, ATS
Chair (2026–2027), Scientific Liaison Coalition